This clinical finding was supported by our preclinical study, in which daily treatment with ACEI or ARB, but not CaB, prevented the development of DPN without affecting the hyperglycemia in leptin-deficient ob/ob mice, a T2DM model. This evidence concerns the gene LEP and type 2 diabetes mellitus.